Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-007294
Filing Date
2015-11-23
Accepted
2015-11-23 06:03:32
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gluc_10q.htm 10-Q 261794
2 CERTIFICATION gluc_ex311.htm EX-31.1 7817
3 CERTIFICATION gluc_ex321.htm EX-32.1 4009
  Complete submission text file 0001477932-15-007294.txt   1252684

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT gluc-20150930.xml EX-101.INS 132254
5 XBRL TAXONOMY EXTENSION SCHEMA gluc-20150930.xsd EX-101.SCH 24720
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gluc-20150930_cal.xml EX-101.CAL 27517
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gluc-20150930_def.xml EX-101.DEF 7158
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE gluc-20150930_lab.xml EX-101.LAB 155096
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gluc-20150930_pre.xml EX-101.PRE 70601
Mailing Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712
Business Address 609 SW 8TH STREET 6TH FLOOR BENTONVILLE AR 72712 (888) 987-6315
Glucose Health, Inc. (Filer) CIK: 0001420108 (see all company filings)

EIN.: 980557171 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55439 | Film No.: 151248224
SIC: 2833 Medicinal Chemicals & Botanical Products